HOME >> BIOLOGY >> NEWS
Women are more likely to suffer recurrent miscarriages if their first child is a boy

Madrid, Spain: Women who give birth to a boy as their first child are more likely to suffer subsequent miscarriages than women whose first baby is a girl, an international conference of fertility experts heard today (Tuesday 1 July).

Dr Ole Christiansen, a consultant registrar at the Rigshospitalet Fertility Clinic in Copenhagen, Denmark, told the annual conference of the European Society of Human Reproduction and Embryology, that giving birth to a boy first was not only a risk factor for subsequent miscarriages, but for women who suffered unexplained secondary recurrent miscarriages (SRM) it could mean that they never managed to carry a child to full term again unless doctors gave them appropriate treatments.

Dr Christiansen said: "Giving birth to a son is known already to be a prognostically negative factor in many obstetrical complications. Therefore we wanted to assess the impact of the gender of the first child on the outcome of subsequent pregnancies among patients with unexplained secondary recurrent miscarriages.[1]"

He studied 204 SRM patients admitted to clinics between 1986 and 2000, and obtained information on subsequent pregnancy outcome in 181 patients admitted before 2000. Among the patients admitted before 2000, only 54.4% of those who gave birth to a boy in their first pregnancy had given birth to a second live baby by January 2002, compared with 73% of women whose first child was a girl.

Amongst a subset of women who did manage to have a second child after a series of miscarriages, those whose first child was a boy had an average of 3.9 miscarriages before achieving a second birth, while women whose first child was girl had 3.5 miscarriages before delivery of a second child a small but statistically significant difference. Average birth weights of the second children tended to be 181g higher where the first-born was a girl.

Dr Christiansen said: "Our study shows that the majority (54.4%) of those
'"/>

Contact: Emma Mason
wordmason@aol.com
44-0-1376-563090
European Society for Human Reproduction and Embryology
1-Jul-2003


Page: 1 2 3

Related biology news :

1. Women who have donated eggs sought for national study
2. Donaghue Womens Health Investigator Program awards grants to three at Yale
3. Top Houston Women in Technology honoree at UH
4. Marie Curie Nobel Centennial Celebration of Women in Science
5. Victoria Hale of Institute for OneWorld Health Named Fellow by International Womens Forum
6. Women who drink may be at greater risk of cardiovascular complications than men
7. Jefferson and Brigham and Womens researchers find blue light important for setting biological clock
8. Womens health issues, child and adolescent disorders featured at APAs annual meeting
9. Women who marry alcoholics
10. Pregnancy hormone induces healthy blood vessels, Magee-Womens Research Institute scientists report
11. US Women scientists from Latin America to encourage colleagues from south

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/10/2017)... Research and Markets has announced the addition ... and Commercial Aspects" to their offering. ... Biomarkers play an ... for selection of treatment as well for monitoring the results. ... in modern medicine. Biochip/microarray technologies and next generation sequencing are ...
(Date:2/8/2017)... NEW YORK , Feb. 7, 2017 Report ... ... and should reach $11.4 billion by 2021, growing at a ... Report Includes - An overview of the global markets for ... from 2015, estimates for 2016, and projections of compound annual ...
(Date:2/7/2017)... Feb. 7, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, will present at the LEERINK Partners 6th Annual ... Hotel on Wednesday, February 15, 2017 at 10 a.m. ... the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  ... conference via Zimmer Biomet,s Investor Relations website at ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... 2017   Capricor Therapeutics, Inc. (NASDAQ: ... developing first-in-class biological therapies for cardiac and other ... to terminate its license agreement with the Mayo ... Cenderitide. "Our decision to return these ... our efforts to advance our core cell and ...
(Date:2/16/2017)... , Feb. 16, 2017  Champions Oncology, Inc. ... the development and sale of advanced technology solutions and ... drugs, today announced the addition of new cohorts of ... These new models will expand Champions, product line in ... and neck cancer, AML, and non-small cell lung cancer ...
(Date:2/16/2017)... WEST LAFAYETTE, Indiana (PRWEB) , ... ... ... a division of Albany Molecular Research Inc. has further extended its industry ... sector. This service offers state-of-the-art cGMP techniques and methods for the ...
(Date:2/15/2017)... Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), today announced financial ... full year ended December 31, 2016. ... we continued to demonstrate strong growth in our ... said Mihael H. Polymeropoulos, M.D., Vanda,s President and ... 2017 milestones underscores Vanda,s commitment to bringing important ...
Breaking Biology Technology:
Cached News: